Trump directed the federal government to rush access to psychedelic treatments and reevaluate their status as controlled ...

As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.” ...

When health care infrastructure is attacked and held for ransom by hackers, patients become real casualties,” writes Andrea ...

Schwartz's background as a physician with plenty of government service experience will likely be popular among lawmakers.

Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...

New research challenges what we know about GLP-1s, vaccine skepticism, and more health news from Morning Rounds ...

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...

Scientists whose work led to powerful obesity drugs like Zepbound are now suggesting targeting the GLP-1 hormone is not ...

New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout ...

The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...

Kennedy Jr. returned to Capitol Hill Thursday, where he defended the administration’s efforts to fight health care fraud and ...

Arbitration decisions, it turns out, are like cockroaches. They’re very hard to kill.